RecruitingNCT00398177
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Sponsor
Stanford University
Enrollment
9,999 participants
Start Date
Jan 1, 1999
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
- Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
- A routine procedure for tissue collection is planned.
- Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria1
- Patients without NHL or Hodgkin's disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00398177
Related Trials
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
NCT02693535166 locations
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
NCT065103613 locations
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
NCT073081327 locations
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
NCT0542166331 locations
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
NCT054425151 location